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Abstract The Drosophila Pan Gu (PNG) kinase complex regulates hundreds of maternal mRNAs
that become translationally repressed or activated as the oocyte transitions to an embryo. In a
previous paper (Hara et al., 2017), we demonstrated PNG activity is under tight developmental
control and restricted to this transition. Here, examination of PNG specificity showed it to be a Thr-
kinase yet lacking a clear phosphorylation site consensus sequence. An unbiased biochemical
screen for PNG substrates identified the conserved translational repressor Trailer Hitch (TRAL).
Phosphomimetic mutation of the PNG phospho-sites in TRAL reduced its ability to inhibit
translation in vitro. In vivo, mutation of tral dominantly suppressed png mutants and restored
Cyclin B protein levels. The repressor Pumilio (PUM) has the same relationship with PNG, and we
also show that PUM is a PNG substrate. Furthermore, PNG can phosphorylate BICC and ME31B,
repressors that bind TRAL in cytoplasmic RNPs. Therefore, PNG likely promotes translation at the
oocyte-to-embryo transition by phosphorylating and inactivating translational repressors.
DOI: https://doi.org/10.7554/eLife.33150.001
Introduction
One of the most dramatic events in development is the transition from differentiated oocyte to toti-
potent embryo, a transition that in nearly all animals occurs in the absence of transcription
(Tadros and Lipshitz, 2009). Thus, translational control of stockpiles of maternal mRNAs is crucial as
the oocyte completes meiosis and resets for embryogenesis, a series of events termed egg activa-
tion (Von Stetina and Orr-Weaver, 2011). In Drosophila, profound changes in mRNA translation
accompany egg activation, with hundreds of maternal mRNAs becoming repressed and nearly a
thousand translationally activated (Kronja et al., 2014). These translation changes occur in a brief
window of less than an hour, and the majority are controlled by the PNG kinase complex
(Kronja et al., 2014). This kinase complex is composed of the PNG catalytic subunit, whose activity
requires the physical association of two activating subunits, GNU and PLU (Freeman et al., 1986;
Elfring et al., 1997; Fenger et al., 2000; Lee et al., 2003). We recently demonstrated that the
activity of PNG is restricted to the window of egg activation by exquisite developmental control of
the binding of GNU to PNG and PLU (Hara et al., 2017).
PNG is likely to have many targets, given that it controls both mRNAs that become repressed
and those that become activated at the oocyte-to-embryo transition (Kronja et al., 2014). PNG pro-
motes the translation of smg mRNA, a translational repressor that can promote deadenylation
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(Tadros et al., 2007; Eichhorn et al., 2016). Most, but not all, of the mRNAs whose translational
repression is dependent on PNG undergo SMG-dependent deadenylation (Eichhorn et al., 2016).
Thus, the role of PNG in translation repression can largely be explained by its effect in activating
translation of smg mRNA. The mechanisms by which PNG promotes translation of activated mRNAs
remain to be uncovered. To determine whether PNG directly controls translational regulators
through phosphorylation, we carried out an unbiased biochemical screen to identify PNG substrates.
Here, we present the results of that screen and evidence that PNG phosphorylates and inactivates
translational repressors.
Results and discussion
PNG is a threonine kinase
As an initial approach to identify substrates for the PNG kinase, predicted to be a Ser/Thr kinase, we
sought to determine whether PNG phosphorylation occurs at consensus sequences. A positional
scanning peptide library (Mok et al., 2010) was treated with active PNG kinase complex or a com-
plex with catalytically inactive PNG (KD: kinase dead) purified from Sf9 cells. Peptides were robustly
phosphorylated by the active PNG kinase complex in contrast to the kinase-dead control
(Figure 1A). PNG exhibited a strong preference to phosphorylate threonine, because peptides
whose phospho-acceptor site (position 0) was fixed with threonine were strongly phosphorylated,
whereas serine peptides were phosphorylated at reduced levels (Figure 1A,B). Although no strong
consensus sequence was identified, PNG was most strongly selective for hydrophobic amino acids at
 3 relative to the phosphorylated residue, and it had some preferences for aromatic residues at
position  2 and for arginine at position +2 (Figure 1B and Figure 1—figure supplement 1).
Increased phosphorylation of peptides with threonine present outside of the intended phospho-
acceptor position was likely an artifact resulting from the presence of two potential phosphorylation
sites.
Kinases with a preference for threonine over serine are atypical, and this specificity is conferred
by a beta-branched amino acid residue immediately downstream of the conserved DFG sequence in
the kinase activation loop (Chen et al., 2014). In PNG, the corresponding amino acid is an isoleu-
cine, which would be predicted to produce a threonine preference (Figure 1C).
Identification of PNG substrates
The peptide arrays did not yield a consensus sequence for PNG of sufficient specificity to be used to
identify putative substrates. We previously had identified a limited number of substrates by DIVEC
screening, in vitro transcribing and translating Drosophila cDNAs, adding recombinant PNG, and
scoring for phosphorylation by gel mobility shift (Lee et al., 2005). Because of the limitations of this
approach, we designed an unbiased biochemical screen. First, we attempted to introduce a muta-
tion into the gatekeeper residue in the ATP-binding pocket of PNG kinase. Replacing the gate-
keeper residue, which is a bulky residue, with a small amino acid allows kinases to utilize ATP
analogs to label substrates (Bishop et al., 2000; Alaimo et al., 2001). Unfortunately, the desired
PNG mutants were inactive (Figure 2—figure supplement 1).
The alternative strategy we employed to isolate PNG substrates was to use purified recombinant
PNG kinase to thio-phosphorylate substrates in embryonic extracts, identifying them by recovery of
thio-phosphorylated peptides by mass spectrometry (Figure 2A). The endogenous kinases in the
extracts from early embryos were inactivated by treatment with 5’-(4-fluorosulphonylbenzoyl)adeno-
sine (FSBA), which covalently binds to kinases at a conserved lysine in the ATP hydrolysis site
(Knight et al., 2012) (Figure 2—figure supplement 2). Wild-type or kinase-dead PNG complex was
expressed in Sf9 cells, purified, and added to the extracts with ATP-gS. Western blot analysis with an
antibody against alkylated-thio-phosphate (Allen et al., 2007) showed that endogenous kinases in
the extract had been inactivated, and phosphorylation occurred with wild-type PNG but not the
kinase-dead form (Figure 2B). Thio-phosphorylated peptides were recovered on iodoacetyl agarose
and identified by mass spectrometry (MS) (Blethrow et al., 2008; Rothenberg et al., 2016). To call
a protein a PNG substrate we demanded that at least two independent phosphopeptides were
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recovered. A pilot screen was done with wild-type PNG kinase and 45 proteins were phosphory-
lated. A second screen was done in which extracts were treated in parallel with wild-type and
kinase-dead PNG. In this second screen, the total representation of peptides in the extract was
quantified by doing mass spec analysis of the peptides that did not bind to iodoacetyl agarose. In
the second experiment, 36 proteins had at least two independent peptides phosphorylated by wild-
type but not kinase-dead PNG. These included 27 of the proteins identified in the pilot experiment
(Figure 2—source data 1).
A high representation of phosphopeptides was recovered for the translational repressor Trailer
Hitch (TRAL) with wild-type but not kinase-dead PNG (Figure 2C). Other phosphorylated proteins
were ribosomal proteins and translation factors, as well as the PLU activating subunit of the PNG
complex. Out of 36 substrates identified, 19 were proteins known to be involved in mRNA transla-
tion. Note that the recovery of substrates was not due solely to the abundance of the proteins in the
extracts (Figure 2—source data 1).
79% of the identified unique peptides had threonine as the phospho-acceptor residue
(Figure 2D). The threonine preference is consistent with the scanning peptide library result
(Figure 1B). The identified peptides showed an enrichment of hydrophobic residues at  3 position
Figure 1. PAN GU (PNG) kinase is a threonine-specific kinase. (A, B) PNG kinase prefers threonine as a phosphoacceptor site. The peptide library was
phosphorylated with PNG kinase wild type (WT) or kinase dead (KD) using radiolabeled ATP (A). The signals were quantified and visualized with
WebLogo 3.0. (B) Ten thousand peptide sequences were generated according to the probabilities predicted from the quantified peptide library data.
The colors designate classes of amino acids. (C) Alignment of the amino acid sequences near the DFG motif of known threonine-specific kinases and
PNG. PNG has a beta-branched residue, isoleucine, immediately downstream of the DFG motif as do other threonine-selective kinases (boxed with
magenta (Chen et al., 2014). The peptide library screen with WT was repeated in four replicates.
DOI: https://doi.org/10.7554/eLife.33150.002
The following source data and figure supplement are available for figure 1:
Source data 1. Quantification of peptide phosphorylation in Figure 1B.
DOI: https://doi.org/10.7554/eLife.33150.004
Figure supplement 1. Heat map for quantified selective values of PNG phosphorylation.
DOI: https://doi.org/10.7554/eLife.33150.003
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Figure 2. Identification of PNG kinase substrates with a biochemical screen. (A) A schematic representation of the substrate screen. Embryo extracts
were gel-filtrated to exchange the buffer and treated with 5’-(4-Fluorosulfonylbenzoyl)adenosine (FSBA) to inactivate endogenous kinases, followed
ammonium sulfate fractionation. The fractionated extracts were dialyzed to remove ammonium sulfate. The recombinant active PNG kinase complex
was added to the FSBA-treated fractions with ATP-gS to thio-phosphorylate PNG kinase substrates. To examine thio-phosphorylated proteins by
immunoblot, they were alkylated with p-Nitrobenzyl mesylate (PNBM), and the alkylated thiophosphate was detected by its specific antibody. For
identification of the thio-phosphorylated peptides, the PNG kinase-treated fractions were pooled and digested with trypsin. Thio-phosphorylated
peptides were purified specifically with iodoacetyl beads and oxsone and identified by mass spectrometry. (B) Detection of thio-phosphoproteins in the
fractions by immunoblots. The FSBA-treated fractions were incubated with wild-type (WT) or kinase-dead (KD) PNG kinase complexes. Thio-
phosphorylated proteins were detected as shown in (A). The PNG kinase complexes added into the fraction were examined by immunoblots using anti-
FLAG (PNG-FLAG), anti-PLU (PLU-His) and anti-GST (GST-GNU) antibodies. (C) A list of PNG substrates identified in the second experiment that were
recovered with wild-type but not kinase-dead PNG. The proteins found by mass spectrometry following purification of the thio-phosphorylated
peptides are listed in the order of the number of total spectrum count of phosphorylated peptides from the sample treated with the wild-type PNG
kinase complex. The top 11 of the 36 substrates identified are shown. (D) Phosphorylation sites analysis. Peptides identified with >95% probability
Figure 2 continued on next page
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as in the peptide library, confirming that PNG tends to phosphorylate threonine three residues
downstream of a hydrophobic amino acid (Figure 2D). The threonine preference was also highly sig-
nificant (log-odds value of 80.5) in the context of the Drosophila proteome (O’Shea et al., 2013).
The correspondence with the peptide sequence preference of PNG is further confirmation that the
observed phosphopeptides likely reflect direct phosphorylation by PNG. Although the substrates
don’t reveal a strong PNG consensus sequence, it is possible that interaction between substrates
and the PLU or GNU activating subunits may provide specificity beyond that at the phosphorylation
site.
Phosphorylation of TRAL by PNG in vitro
We focused on TRAL, because although there were many more abundant proteins in the extracts,
we recovered a high number of PNG-phosphorylated peptides for TRAL. TRAL is a member of the
(L)Sm protein family composed of RAP55 in vertebrates, CAR1 in C. elegans, and Sdc6 in yeast
(Wilhelm et al., 2005; Marnef et al., 2009). We tested whether PNG can phosphorylate TRAL in
vitro. A powerful aspect of the thio-phosphate substrate screen is that the MS analysis identifies the
phosphorylated amino acids. 15 amino acids (13 of them threonine), clustered in the C-terminal half
of the protein, were phosphorylated by PNG in embryonic extracts (Figure 3A). MBP fusions of puri-
fied full length TRAL, or the N- and C- terminal fragments were incubated with purified PNG and [g
32P]-ATP and analyzed by autoradiography. The full-length protein and the C-terminal half, but not
the N-terminal half, were phosphorylated by PNG in vitro (Figure 3B). To determine whether PNG-
dependent phosphorylation required the amino acids identified in the substrate screens, all 15 were
changed to alanine. For both the full-length protein and the C-terminal half, the level of phosphory-
lation by PNG was reduced with the alanine-substituted forms (Figure 3B). Residual phosphorylation
of the alanine-substituted form of TRAL raises the possibility that there are other potential PNG
phosphorylation sites in the C-terminus of TRAL that were not detected in the screen.
We next wanted to investigate whether phosphorylation of TRAL by PNG inhibits its activity.
RAP55 from Xenopus and Sdc6 from yeast are able to inhibit translation in vitro (Tanaka et al.,
2006; Nissan et al., 2010), in yeast apparently by blocking the function of the eIF4G subunit of the
eIF4F initiation factor (Rajyaguru et al., 2012). We examined translation of an mRNA encoding Myc-
tagged GFP in reticulocyte lysates and found that as for other family members, addition of Drosoph-
ila TRAL inhibited translation (Figure 3C). Because in the in vitro reaction purified PNG does not
phosphorylate TRAL to full stoichiometry, we evaluated the effect of PNG phosphorylation by gener-
ating a phosphomimetic form of TRAL in which aspartic acid was substituted for the fifteen PNG
phosphorylation sites. Strikingly, the phosphomimetic mutations suppressed the translational repres-
sion by TRAL (Figure 3C). The potential existence of additional PNG phosphorylation sites in the
C-terminus of TRAL could account for why suppression of translational repression by the phosphomi-
metic form of TRAL was not complete. In contrast, TRAL in which these residues were replaced by
alanine still inhibited translation of the reporter mRNA in the extracts (Figure 3C). These results are
consistent with phosphorylation of TRAL by PNG relieving its ability to repress translation.
Figure 2 continued
according to Scaffold were used for thio-phosphorylation motif analysis. Phosphopeptides identified in the samples treated with the PNG WT kinase
complex but absent from the samples treated with KD kinase were further analyzed. Since elution of the peptides was performed under oxidizing
conditions, peptides that differed only in the oxidation state of their methionines were regarded as equal. A total of 112 unique phosphopeptides
belonging to 70 different proteins were considered. Using these phosphopeptides, a list of motifs was constructed centered on the phosphosite and
including the 5 N-terminal and 4 C-terminal residues found adjacent to the phosphosite on the protein and analyzed with WebLogo 3.0. The screen
with the WT kinase was done as a pilot screen, and a second experiment was done in which the results were compared with kinase-dead PNG.
DOI: https://doi.org/10.7554/eLife.33150.005
The following source data and figure supplements are available for figure 2:
Source data 1. Lists of proteins and peptides identified by mass spectrometry analyses.
DOI: https://doi.org/10.7554/eLife.33150.008
Figure supplement 1. Mutation of the gatekeeper residue of PNG inactivates its kinase activity.
DOI: https://doi.org/10.7554/eLife.33150.006
Figure supplement 2. 5’-(4-Fluorosulfonylbenzoyl)adenosine (FSBA) inactivates endogenous kinases in the embryo extracts.
DOI: https://doi.org/10.7554/eLife.33150.007
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Figure 3. PNG kinase directly phosphorylates Trailer hitch (TRAL) and can suppress its repressor function. (A) Schematic representation of Trailer hitch
(TRAL) protein. Drosophila melanogaster TRAL consists of 652 amino acids and has conserved domains: the LSm (Like Sm) domain is essential for
P-body localization of TRAL; the FDF domain binds to ME31B, a translational repressor (Marnef et al., 2009). The phosphorylation sites of TRAL
identified in the screen map exclusively to the C-terminus. (B) PNG kinase phosphorylates the C-terminus of TRAL in vitro. Maltose-binding protein
(MBP)-fused full length (FL) and N- and C-terminal fragments (N: 1–355 and C: 356–652, respectively) of TRAL were expressed and purified from
bacteria (A). The MBP-fused TRAL proteins were incubated with the active PNG kinase complex in the presence of radioactive ATP. Incorporated
radioactivity in the TRAL proteins was detected by autoradiography. The levels of the MBP-fused TRAL proteins were examined by coomassie staining
(CBB). The active PNG kinase complex in the reactions also was examined by immunoblot using anti-GST (GST-GNU), anti-FLAG (PNG-FLAG) and anti-
PLU (PLU-His) antibodies. Substitution of the phosphosites in TRAL to alanine (FL-A and C-A) reduced phosphorylation by PNG. The kinase assay was
repeated three times. Representative results are shown. (C) Phosphomimetic mutation of the PNG phosphorylation sites in TRAL suppresses
translational repression activity of TRAL in vitro. In vitro transcribed GFP-3xMyc mRNA was translated in rabbit reticulocyte lysate with or without MBP-
fused TRAL wild-type (WT) or MBP-TRAL mutant proteins, which have alanine or aspartic acid in the PNG phosphorylation sites (Ala or Phos-mimic).
MBP was used as a control. Translation of GFP-3xMyc mRNA was examined by GFP-3xMyc protein levels on an immunoblot using anti-Myc antibody.
MBP and MBP-fused TRAL protein levels were examined by immunoblot using anti-MBP antibody. GFP-3xMyc protein levels were quantified and
normalized to its levels in the control reaction. Error bars represent standard deviation (n = 4, unpaired t-test; mean ± SD). Representative blots are
shown. (D, E) tral dominantly suppresses png phenotypes. (D) Embryos from females whose genotype were png1058/png3318 with Df(3L)ED4483/+ (Df/+)
or tral1/+ (tral/+) were collected, fixed, and DNA stained with DAPI. Nuclear numbers in the embryos were quantified by fluorescent microscopy. TM6C,
cu1 Sb1/+ (TM6/+) and TM3, Sb1 Ser1/+ (TM3/+) were used as controls for Df/+ and tral/+, respectively. The results are the sum of three experiments,
and their significance was tested with Fisher’s exact test. (E) Cyclin A and B (CycA, CycB) protein levels of the embryos from the females with the
indicated genotypes were examined by immunoblot. Alpha-tubulin (TUB) was used as a loading control. The asterisk shows a non-specific band.
DOI: https://doi.org/10.7554/eLife.33150.009
The following source data and figure supplements are available for figure 3:
Source data 1. Quantification of GFP protein levels in Figure 3C.
DOI: https://doi.org/10.7554/eLife.33150.013
Source data 2. Raw data of embryo numbers for Figure 3D.
DOI: https://doi.org/10.7554/eLife.33150.014
Figure supplement 1. TRAL phosphorylation analysis by quantitative mass spectrometry.
Figure 3 continued on next page
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Interaction between PNG and TRAL in vivo
To confirm that PNG phosphorylates TRAL in vivo we analyzed TRAL phosphorylation by MS follow-
ing immunoprecipitation from extracts of mature oocytes, in vitro activated oocytes or early
embryos. The phosphorylation pattern of TRAL during egg activation was very complex, with many
sites. As a consequence, we could find only a small number of phospho-peptides in our quantitative
MS analysis, because multiple phosphorylation in a peptide can impede detection of other phospho-
sites on the peptide after LC/MS. Nevertheless, we did observe that one of the threonine residues
(T644) phosphorylated in vitro became phosphorylated at egg activation in wild-type but not png
mutant eggs (Figure 3—figure supplement 1). Phosphorylation levels of several residues (T35, S59,
S472) were reduced in the activated oocytes from the png mutant, although they were not found in
the substrate screen. These might be potential PNG kinase target sites, but they also could be phos-
phorylated downstream of PNG indirectly. The proposal of phosphorylation downstream of PNG is
consistent with two of these being in the N-terminus of TRAL that is not phosphorylated by PNG in
vitro, and the observation that S214 phosphorylation is increased in png mutant activated oocytes.
Together these results support the conclusion that TRAL is a PNG substrate, but they reveal that
TRAL phosphorylation is developmentally dynamic and involves several kinases.
Therefore, we looked for genetic interactions between png and tral mutants. The png gene was
identified because mutant females produce eggs that complete meiosis but subsequently fail to initi-
ate mitotic divisions (Shamanski and Orr-Weaver, 1991). Nevertheless, DNA replication continues,
resulting in embryos with giant, polyploid nuclei. In strong alleles of png there is no mitosis, whereas
weaker alleles permit a few mitotic divisions but these nuclei ultimately also become polyploid
(Shamanski and Orr-Weaver, 1991; Lee et al., 2001). The absence of mitosis in png mutants is due
to a failure to promote cyclin B mRNA translation at egg activation (Vardy and Orr-Weaver, 2007;
Kronja et al., 2014). We demonstrated that removal of one copy of some genes (such as the transla-
tional repressor pum, discussed below) can suppress the giant-nuclei png phenotype, resulting in
embryos that undergo more mitotic divisions and thus have more nuclei (Lee et al., 2001). If the
gene acts downstream of png, this suppression is consistent with png acting negatively on the gene.
In contrast, removal of one copy of a gene such as cyclin B enhances the png phenotype, consistent
with png having a positive effect on this gene (Lee et al., 2001).
We compared embryos laid by females with png1058/png3318 with one copy of tral mutated to sib-
ling controls solely mutant for png. Reducing the dosage of tral (a heterozygous tral1 mutation,
which has a P element insertion) suppressed the png phenotype, permitting additional mitoses and
increased numbers of nuclei (Figure 3D, Figure 3—figure supplement 2). This suppression was
even more pronounced with a deletion that completely removes the tral gene (heterozygous Df(3L)
ED4483) (Figure 3D, Figure 3—figure supplement 2). These genetic epistasis results complement
the in vitro translation results with the phosphomimetic TRAL form. They are consistent with TRAL
being a target of PNG and phosphorylation negatively affecting TRAL.
To test whether the genetic interactions between tral and png affect cyclin B mRNA translation,
we examined protein levels by immunoblotting of extracts from the mutant and control embryos.
Strikingly, Cyclin B protein levels were increased in the png transheterozygous embryos when the
dosage of tral was reduced (Figure 3E). Consistent with the suppression phenotypes, the amount of
Cyclin B was restored more with the deletion than with the tral1 allele. Cyclin A, another PNG trans-
lational target, also was increased with reduced TRAL.
Taken together, the in vitro and in vivo phosphorylation results and the genetic interaction data
indicate that phosphorylation of TRAL by PNG blocks its repressive effects on translation, permitting
translation of cyclin B at egg activation to permit embryonic mitoses. This could be due to PNG
phosphorylation directly repressing TRAL function or via an effect of phosphorylation on the
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.33150.010
Figure supplement 1—source data 1. Quantification of phosphopeptide recovery.
DOI: https://doi.org/10.7554/eLife.33150.011
Figure supplement 2. Examples of DAPI-stained embryos scored in Figure 3D.
DOI: https://doi.org/10.7554/eLife.33150.012
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localization of TRAL. TRAL is present in large cytoplasmic RNP granules in mature oocytes in both
Drosophila and C. elegans, and these disperse on egg activation (Weil et al., 2012; Noble et al.,
2008). Thus, one model for the effect of PNG on TRAL is that phosphorylation could affect the local-
ization of TRAL to RNP granules. We examined these large visible granules using a GFP-Tral FlyTrap
line with or without png mutations and following TRAL localization during in vitro egg activation. We
found that early in activation, by about 10 min, TRAL granules became diminished (Figure 4A). In
png mutant eggs, the TRAL granules also disappeared with normal timing (Figure 4A).
We conclude that PNG does not appear to be involved in this reorganization of TRAL granules.
Indeed, dispersal of TRAL from granules occurs prior to when PNG becomes active at 30 min after
egg activation (Hara et al., 2017). PNG phosphorylation may more directly affect the ability of TRAL
to inhibit translation initiation, as indicated by the effect of the phosphomimetic form on translation
in reticulocyte lysates.
PNG phosphorylates other translational repressors
Given the hundreds of mRNAs whose regulation at egg activation is dependent on PNG, it seemed
probable that PNG affects translation through multiple mechanisms and may have multiple substrate
targets. We previously showed that the translational repressor pumilio (pum) dominantly suppresses
png; a heterozygous mutation of pum restores both Cyclin B protein levels and mitosis in png
mutant embryos (Vardy and Orr-Weaver, 2007). Even PUM nonphosphorylated peptides were not
recovered in the substrate screen (Figure 2—source data 1), therefore, the possibility of PUM being
a PNG substrate could not be evaluated. Consequently, we tested for a direct interaction between
png and pum by asking whether PNG can phosphorylate PUM in vitro. A GST-PUM fusion protein is
phosphorylated by purified wild-type PNG kinase but not by the kinase-dead form (Figure 4B).
The ME31B RNA helicase acts as a translational repressor (Nakamura et al., 2001) and is a bind-
ing partner to TRAL (Tritschler et al., 2008). We did not recover it above the cut off in the substrate
screen, although one ME31B phosphopeptide was present in the wild-type but not kinase-dead
PNG sample (Figure 2—source data 1). Given its interaction with TRAL, we directly tested ME31B
in vitro and found that PNG was able to phosphorylate it (Figure 4C). Thus, PNG phosphorylation
may affect both of these conserved proteins and their role as a complex in controlling translation.
Another translational regulator that is a potential PNG substrate is BICC. BICC binds to the GNU
subunit of the PNG complex directly through its SAM domain (Chicoine et al., 2007) (Hara and Orr-
Weaver unpublished), and BICC also is known to physically interact with TRAL (Kugler et al., 2009).
We did not, however, recover BICC from the substrate screen. Despite this, PNG readily phosphory-
lates BICC in vitro (Figure 4B).
These results raise the possibility that PNG acts on a number of translational repressors. The two
PNG substrate screens likely were not saturating to identify all potential translational repressor tar-
gets. The translational repressors Cup and Caprin were recovered in the first substrate screen but
not by our criteria in the second. The dominant genetic suppression of png observed with mutation
of tral or pum generates the hypothesis that PNG may inactivate multiple translational repressors by
phosphorylation to promote translation of different sets of mRNAs at egg activation. It is also possi-
ble that PNG’s effect on multiple repressors may target a single set of mRNAs localized to RNP
granules. For example, ME31B is bound to TRAL. BicC genetically interacts with tral, the protein
appears to localize to the RNP granules in which TRAL and ME31B reside, and it binds to GNU
(Kugler et al., 2009; Chicoine et al., 2007). From these observations, PNG might phosphorylate
multiple targets on RNP granules to de-repress translational inhibition of maternal mRNAs at egg
activation.
In addition to its effects at egg activation, PNG may indirectly affect translational repressors later
in embryogenesis, at a developmental time when PNG appears to be inactivated (Hara et al.,
2017). In the embryo the TRAL, ME31B, and Cup proteins form an inhibitory complex that represses
the translation of maternal mRNAs. These proteins have been shown to be degraded during the
maternal-to-zygotic transition, and functional PNG is a prerequisite for this degradation
(Wang et al., 2017).
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Figure 4. PNG kinase phosphorylates translational repressors in vitro. (A) TRAL granules in oocytes diminished
after egg activation independently of png. Heterozygous (png1058/FM7B wa) or homozygous png (png1058/png1058)
oocytes expressing GFP-Tral (GFP-Tral89/TM3 Sb) were activated in vitro. GFP-TRAL signal in the oocytes was
observed by confocal microscopy. Time in the images indicates time after egg activation. Bar indicates 100 mm.
Figure 4 continued on next page
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Conclusions
We previously showed that the PNG kinase is activated by a signal downstream of egg activation
and thus controls massive changes in maternal mRNA translation (Kronja et al., 2014; Hara et al.,
2017). We now have found TRAL is a PNG substrate using a biochemical screen. Phosphorylation by
PNG suppressed TRAL’s ability to repress mRNA translation. This antagonism also was supported by
genetic interaction between png and tral in fertilized embryos, suggesting that TRAL phosphoryla-
tion by PNG during the oocyte-to-embryo transition is a key to remodel maternal mRNAs’ transla-
tion activity.
The PNG kinase functions as a signal transducer for the external egg activation signal to mRNA
translation in the cytoplasm in the activated eggs (Hara et al., 2017). Similar strategies can be used
in oocyte maturation, during which a hormonal signal leads to phosphorylation of translational regu-
lators to control mRNA translation (Radford et al., 2008). In neurons, stimuli cause translocation of
mRNA followed by translational activation (Yoon et al., 2016). Understanding signaling pathways
that transmit extracellular signals to translational controls thus is likely to provide us insight into
molecular mechanisms in fertility as well as synaptic plasticity and memory.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
gene (Drosophila
melanogaster)
Bicaudal C (BicC) NA FLYB: FBgn0000182
gene
(D. melanogaster)
giant nuclei (gnu) NA FLYB: FBgn0001120
gene
(D. melanogaster)
maternal expression
at 31B (me31B)
NA FLYB: FBgn0004419
gene
(D. melanogaster)
pan gu (png) NA FLYB: FBgn0000826
gene
(D. melanogaster)
plutonium (plu) NA FLYB: FBgn0003114
gene
(D. melanogaster)
pumilio (pum) NA FLYB: FBgn0003165
gene
(D. melanogaster)
trailer hitch (tral) NA FLYB: FBgn0041775
strain, strain
background
(D. melanogaster)
WT: OregonR NA
Continued on next page
Figure 4 continued
Representative oocytes images, taken with the same exposure settings, are shown (WT: n = 8, png: n = 3) (B) PNG
kinase phosphorylates Bicaudal C (BICC) and Pumilio (PUM). GST-fused BICC and PUM were incubated with or
without wild-type (WT) or kinase-dead (KD) PNG kinase activated with MBP-GNU in the presence of radioactive
ATP. Radioactivity incorporated into proteins was detected by autoradiography (left panel). The substrate protein
levels were examined by coomassie staining (right panel, CBB). MBP-GNU and PNG protein levels were examined
by immunoblot using anti-MBP (MBP-GNU) and anti-FLAG (PNG-FLAG) (bottom panels, WB). The kinase
assay was repeated in two replicates. Representative results are shown. (C) PNG kinase phosphorylates ME31B in
vitro. Recombinant His-ME31B was incubated with or without PNG kinase complex in the presence of radioactive
ATP. Because PNG kinase complex requires additional recombinant GNU (GST-GNU) for its full kinase activation,
His-ME31B was phosphorylated with or without GST-GNU. Radioactivity incorporated into His-ME31B was
detected by autoradiography (left panel). Protein levels of His-ME31B were examined by coomassie staining (right
panel, CBB). The white arrowhead indicates phosphorylated His-ME31B protein. The kinase assay was repeated in
two replicates. Representative results are shown.
DOI: https://doi.org/10.7554/eLife.33150.015
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
genetic reagent
(D. melanogaster)
Df(3L)ED4483 Bloomington Drosophila
Stock Center
BDSC:8070;
RRID:BDSC_8070;
FLYB:FBst0008070
FlyBase symbol: Df(3L)ED4483;
Genotype: w[1118];
Df(3L)ED4483, P{w[+mW.
Scer\FRT.hs3]=3’.RS5+3.3’}
ED4483/TM6C, cu[1] Sb[1]
genetic reagent
(D. melanogaster)
gfp-tral89 The Flytrap Project;
(Morin et al., 2001);
PMID:11742088
Flytrap:G00089;
DGRC:110584;
RRID:DGGR_110584
Genotype: w[*];
P{w[+mC]=PTT-un1}G00089
genetic reagent
(D. melanogaster)
png1058 (Shamanski and Orr-Weaver, 1991);
PMID:1913810
genetic reagent
(D. melanogaster)
png3318 (Shamanski and Orr-Weaver, 1991);
PMID:1913810
genetic reagent
(D. melanogaster)
tral1 Bloomington Drosophila
Stock Center;
(Wilhelm et al., 2005);
PMID: 16256742
BDSC:14933;
RRID:BDSC_14933;
FLYB:FBst0014933
Genotype: y[1];
P{y[+mDint2] w[BR.E.BR]=
SUPorP}tral[KG08052]
ry[506]/TM3, Sb[1] Ser[1]
antibody alkylated
thiophosphate
antibody (Rabbit
monoclonal)
Abcam Abcam:ab92570;
RRID:AB_10562142
Anti-Thiophosphate ester
antibody [51-8] (1/2000 in
5% Skim milk TBS-T)
antibody anti-PNG (Rabbit
polyclonal)
(Hara et al., 2017);
PMID: 28555567
(1/1000 in Hikari solution A)
antibody anti-PLU (Rabbit
polyclonal)
(Elfring et al., 1997);
PMID: 9247640
Affinity-purified (1/200
in Hikari solution A)
antibody anti-GNU (Guinea pig
polyclonal)
(Lee et al., 2003);
PMID: 14665672
(1/5000 in TBS-T)
antibody anti-TRAL
(Rat polyclonal)
(Tritschler et al., 2008);
PMID:18765641
antibody anti-FLAG (Mouse
monoclonal)
Sigma-Aldrich Sigma-Aldrich:F1804;
RRID:AB_262044
(1/2000 in TBS-T)
antibody anti-MBP (Rat
monoclonal)
Sigma-Aldrich Sigma-Aldrich:SAB4200082 (1/2000 in Hikari solution A)
antibody anti-Myc (Mouse
monoclonal)
Covance Covance:MMS-150R-1000;
RRID:AB_291325
9E10; (1/2000 in TBS-T)
antibody anti-GST (Mouse
monoclonal)
MBL MBL:PM013-7;
RRID:AB_10598029
Anti-GST-tag
pAb-HRP-DirecT;
(1/5000 in Hikari solution A)
antibody HRP-conjugated
anti-rabbit IgG
Jackson Immuno
Research
Jackson
ImmunoResearch:
711-035-152;
RRID:AB_10015282
(1/10000 in TBS-T or
Hikari solution B)
antibody HRP-conjugated
anti-guinea pig IgG
Jackson Immuno
Research
Jackson Immuno
Research:706-035-148:
RRID:AB_2340447
(1/50000 in TBS-T)
antibody HRP-conjugated
anti-mouse IgG
Jackson Immuno
Research
Jackson Immuno
Research:115-035-164:
RRID:AB_2338510
(1/20000 in TBS-T)
antibody HRP-conjugated
anti-rat IgG
Jackson Immuno
Research
Jackson Immuno
Research:112-035-062:
RRID:AB_2338133
(1/5000 in TBS-T)
antibody mouse
monoclonalanti
-Cyclin A
Developmental Studies
Hybridoma Bank
DSHB Cat #A12
RRID:AB_528188
1/100 in Hikari
Solution A
antibody mouse
monoclonalanti-
Cyclin B
Developmental Studies
Hybridoma Bank
DSHB Cat#F2F4
RRID:AB_528189
1/200 in Hikari
Solution B
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
recombinant
DNA reagent
pFastBac Dual Thermo Fisher Thermo Fisher:10712024
recombinant
DNA reagent
pFastBac1 Thermo Fisher Thermo Fihser:10359016
recombinant
DNA reagent
pGEX-6P-1 GE Healthcare GE Healthcare:28954648
recombinant
DNA reagent
pMAL-c2X New England
Biolabs
New England
Biolabs:N8076S
recombinant
DNA reagent
pSP64 Poly(A) Promega Promega:P1241
recombinant
DNA reagent
pET28b Merck Merck:69865- 3
recombinant
DNA reagent
pFastBac Dual
PNG/PLU
(Hara et al., 2017);
PMID: 28555567
recombinant
DNA reagent
pFastBac Dual
PNG172/PLU
This paper png172:kinase dead
mutant (G157E)
recombinant
DNA reagent
pFastBac1 GNU (Lee et al., 2003);
PMID: 14665672
recombinant
DNA reagent
pFastBac Dual
PNG M87G/PLU
This paper PNG M87G: gatekeeper
mutant
recombinant
DNA reagent
pFastBac Dual
PNG M87A/PLU
This paper PNG M87A: gatekeeper
mutant
recombinant
DNA reagent
pGEX-6P-1 GNU (Hara et al., 2017);
PMID: 28555567
recombinant
DNA reagent
pGEX-6P-1
BICC
This paper
recombinant
DNA reagent
pGEX-6P-1
PUMILIO
This paper
recombinant
DNA reagent
pMAL-c2X
GNU
This paper
recombinant
DNA reagent
pMAL-c2X
TRAL FL
This paper
recombinant
DNA reagent
pMAL-c2X
TRAL N
This paper TRAL 1–355
recombinant
DNA reagent
pMAL-c2X
TRAL C
This paper TRAL 356–652
recombinant
DNA reagent
pMAL-c2X
TRAL FL A
This paper T438A, T441A, T444A, T446A,
T448A, T526A, T528A, S532A,
S533A, T534A, T630A, T631A,
T633A, T634A, T644A
recombinant
DNA reagent
pMAL-c2X
TRAL C A
This paper T438A, T441A, T444A, T446A,
T448A, T526A, T528A, S532A,
S533A, T534A, T630A, T631A,
T633A, T634A, T644A
recombinant
DNA reagent
pMAL-c2X
TRAL FL
Phos-mimic
This paper T438D, T441D, T444D, T446D,
T448D, T526D, T528D, S532D,
S533D, T534D, T630D, T631D,
T633D, T634D, T644D
recombinant
DNA reagent
pSP64 Poly(A)
EGFP-3xMyc
This paper
recombinant
DNA reagent
pET28b
ME31B-3xMyc
This paper
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
commercial
assay or kit
mMESSAGE
mMACHINE
SP6 Transcription
Kit
Thermo Fisher Thermo Fisher:AM1340
commercial
assay or kit
Rabbit Reticulocyte
Lysate System,
Nuclease Treated
Promega Promega: L4960
commercial
assay or kit
TMTsixplex
Isobaric Label
Reagent Set
Thermo Fisher Thermo Fisher:90061
chemical compound,
drug
FSBA SIGMA-Aldrich SIGMA-Aldrich:F9128 5’-(4-fluorosulphonylbenzoyl)
adenosine
chemical compound,
drug
PNBM Abcam Abcam:ab138910 p-Nitrobenzyl mesylate
chemical compound,
drug
N6(benzyl) ATP-gS Axxora Axxora:BLG-B072
chemical compound,
drug
N6(phenethyl)
ATP-gS
Axxora Axxora:BLG-P026 N6(Phenylethyl) ATP-g-S
chemical compound,
drug
N6(furfuryl)
ATP-gS
Axxora Axxora:BLG-F008
chemical compound,
drug
HIKARI signal
enhancer
Nacalai Nacalai:02270–81 Signal Enhancer
HIKARI for
Western Blotting
and ELISA
software, algorithm WebLogo (Crooks et al., 2004);
PMID:15173120
RRID:SCR_010236
software, algorithm Proteome Discoverer Thermo Fisher RRID:SCR_014477
software, algorithm Mascot Matrix Science RRID:SCR_014322
software, algorithm CAMV (Curran et al., 2013);
PMID:23500044
Fly stocks and embryo collection
Oregon R was used as the wild-type control. The mutants we used were: png1058 and png3318
(Shamanski and Orr-Weaver, 1991); tral1 and Df(3L)ED4483 (Wilhelm et al., 2005) (Bloomington
stock center); GFP-Tral89 (Morin et al., 2001) (FlyTrap project). Flies were maintained at 22 or 25˚C
on standard Drosophila cornmeal molasses food.
Positional scanning peptide libraries
To examine whether PNG kinase had preferred phospho motifs, we screened a positional scanning
peptide library as described (Mok et al., 2010). Peptide mixtures (50 mM) having the general
sequence Y-x-x-x-x-x-S/T-x-x-x-x-A-G-K-K(biotin) were incubated with 1.5 ng/mL of either of the puri-
fied recombinant active wild-type or kinase-deficient (PNG172) (Fenger et al., 2000) PNG kinase
(Hara et al., 2017) and 4.9 ng/mL GST-GNU at 30 ˚C for 2 hr in kinase reaction buffer (50 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 3 mM MnCl2, 1 mM DTT, 80 mM b-glycerophosphate (bGP), 0.1% BSA,
0.1% Tween 20) containing 50 mM g [33P]-ATP (0.03 mCi/mL). Peptide aliquots were transferred to
streptavidin-coated membrane, which was processed as described (Mok et al., 2010). Radiolabel
incorporation was quantified by phosphor imaging using Quantity One software (Bio Rad). The phos-
phorylation motifs were visualized using WebLogo (Crooks et al., 2004).
PNG kinase substrate screen
Wild-type embryos (0–2 hr) were collected (Hara et al., 2017), homogenized in embryo lysis buffer
[50 mM Tris-HCl pH8.0, 150 mM NaCl, 15 NP-40, 1 mM DTT, 2.5 mM EGTA, Complete EDTA-free
protease inhibitor (Roche, Indianapolis, IN)], and then sonicated. After centrifugation at 14 krpm for
15 min at 4˚C, the supernatant was applied to a PD10 desalting column (GE Healthcare, Waukesha,
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WI) to change its buffer into kinase buffer [20 mM Tris-HCl pH7.5, 3 mM MnCl2, 10 mM MgCl2, 80
mM bGP, 0.5mM DTT, Complete EDTA-free protease inhibitor (Roche, Indianapolis, IN)] and treated
with 1 mM FSBA for 45 min at room temperature. The extracts were fractionated with ammonium
sulfate precipitation at 25%, 40%, 50%, 60% and 75% saturation, and the precipitates of each frac-
tion were frozen in liquid N2 and stored at  80˚C. They were separately resuspended in the same
volume of kinase buffer as the initial extract volume and were dialyzed in kinase buffer to remove
ammonium sulfate and free FSBA. If fractions had remaining endogenous kinase activities, they were
treated with FSBA again and dialyzed to remove it. To thio-phosphorylate proteins in the fractions,
500 mL of each fraction was incubated with the recombinant wild-type or kinase-dead PNG kinase
complex (600 ng of PNG-FLAG), GST-GNU (2 mg) to activate the kinase (Hara et al., 2017), and 1
mM ATP-gS in kinase buffer supplemented with 0.1 mM okadaic acid at 30˚C for 30 min. Twenty
microliters of the reaction were taken from each and alkylated with PNBM to test for thio-phosphor-
ylation by immunoblot using an alkylated thiophosphate antibody (Anti-Thiophosphate ester anti-
body [51-8]; Abcam. Cambridge, MA) (Allen et al., 2007). The remainder of each reaction was
methanol-chloroform extracted and trypsinized. In the first experiment, the 25% ammonium sulfate
fraction and a pooled fraction (40%, 50%, 60% and 75%) were analyzed, whereas all ammonium sul-
fate fractions were combined and analyzed in the second experiment. Thio-phosphorylated peptides
were captured onto an iodoacetyl resin, stringently rinsed, eluted by oxidation with Oxone, and
identified by MS as previously described (Rothenberg et al., 2016).
Recombinant proteins
The regions of the tral cDNA corresponding to coding frame for full length (FL: 1–652 amino acids),
the N-terminus (1–355 amino acids) or the C-terminus (356–652 amino acids) of the TRAL protein
were cloned into pMAL-c2x (NEB, Ipswich, MA) to express maltose binding protein (MBP) fusion
proteins in bacteria. Phosphomutants of the residues identified as PNG phosphorylation sites in the
substrate screen were made in the tral C-terminus cDNA. The threonine or serine phosphosites were
substituted to alanine (A) or aspartic acid (Phos-mimic) by gene synthesis (GENEWIZ, South Plain-
field, NJ). The mutated cDNAs were cloned into pMAL-c2x (NEB, Ipswich, MA) for analysis of solely
the C-terminal fragment or were swapped with the C-terminus of the pMAL-c2x TRAL Full Length
(FL) cDNA clone to make pMAP-c2x TRAL FL A or Phos-mimic. MBP-fusion proteins were expressed
and purified from bacteria following manufacturer protocols (NEB, Ipswich, MA) and dialyzed in TBS
with 0.05% NP-40 and 1 mM DTT.
PUM and BICC FL cDNA were cloned into pGEX-6P-1 (GE Healthcare, Waukesha, WI) to express
them as GST fusion proteins in bacteria. The fusion proteins were purified using manufacturer proto-
cols (GE Healthcare, Waukesha, WI) and dialyzed in TBS with 0.05% NP-40 and 1 mM DTT.
To make MBP-fused GNU, GNU cDNA was cloned into pMAL-c2x (NEB, Ipswich, MA), expressed
and purified from bacteria as above.
ME31B fused with 3xMyc was cloned into pET28b to express as a His-tagged protein in bacteria.
The protein was purified using Ni-NTA beads (Qiagen) and following manufacturer protocols.
In vitro kinase assay
Two mg of MBP-TRAL were incubated with the recombinant PNG kinase complex (6 ng of PNG-
FLAG) and 20 ng GST-GNU to activate PNG kinase at 30˚C for 5 min in 10 mL of kinase buffer2 [20
mM Tris-HCl pH7.5, 3 mM MnCl2, 10 mM MgCl2, 80 mM bGP, 10 mM ATP, Complete EDTA-free
protease inhibitor (Roche, Indianapolis, IN)] in the presence of 11.1 MBq/mL [g-32P]ATP. Reactions
were terminated by adding 5 mL of 3x Laemmli sample buffer (LSB) with 25 mM EDTA and boiling.
Samples were separated on 7.5% SDS-PAGE, and after Coomassie Brilliant Blue (CBB) staining phos-
phorylated TRAL was detected by autoradiography. The recombinant PNG kinase components were
examined by immunoblot as described before (Hara et al., 2017). GST-PUM and GST-BICC were
treated with WT or kinase-dead PNG kinase complex, and their phosphorylation was detected as
above except that MBP-GNU was used to activate PNG kinase instead of GST-GNU.
In vitro translation assay
EGFP-3x Myc cDNA mRNA was in vitro transcribed from its cDNA cloned into pSP64 poly(A) using
mMESSAGE mMACHINE (ThermoFisher, Waltham, MA). The mRNA was translated in the rabbit
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reticulocyte lysate system (Promega, Madison, WI) with or without 1 mM (final) MBP or MBP-TRAL
proteins. Synthesized EGFP-3x Myc protein and MBP or MBP-TRAL proteins from the reaction were
examined by immunoblot with anti-Myc (9E10; Covance, Princeton, NJ) or Anti-MBP antibody
(Sigma-Aldrich, St. Louis, MO).
Embryo collection and staining
Fertilized embryos were collected for 2 hr and aged for 1 hr, dechorionated, fixed and the DNA
stained with DAPI (Pesin and Orr-Weaver, 2007). Their nuclear number was scored as previously
described (Lee et al., 2001). For immunoblots, dechorionated embryos were lysed in 1x LSB and
Cyclin A and B proteins were probed as described (Hara et al., 2017).
In vitro activation and GFP-TRAL imaging
Stage 14 oocytes were collected from png1058/FM7wa;GFP-Tral89/TM3Sb or png1058/png1058;GFP-
Tral89/TM3Sb females in isolation buffer and placed between a glass slide and cover slip separated
with double sticky tape as a spacer. The oocytes in the chamber were activated with activation buffer
(Mahowald et al., 1983). GFP-TRAL in the cytoplasm was inspected by confocal microscopy (Zeiss
LSM700).
Trailer Hitch phospho-site mapping
Stage 14 oocytes, in vitro activated eggs (30 min) and fertilized embryos (1 hr collection) from WT
(OrR) or png mutant (png1058/1058) females were homogenized in lysis buffer supplemented with
RNase A (0.1 mg/mL). Soluble fractions were recovered after centrifugation and their protein con-
centration was adjusted to 5 mg/mL. Forty mL of the soluble fractions was used for immunoprecipi-
taion for TRAL. Protein G Dynabeads (Thermo Fisher Scientific, Waltham, MA) were incubated with
anti-TRAL antibody (a gift from Izaurralde lab), washed and cross-linked by BS3 (Thermo Fisher Scien-
tific, Waltham, MA) following protocols from the manufacturer. The beads were incubated with the
soluble fractions from above for 2 hr at 4oC. After washing the beads three times with lysis buffer,
immunoprecipitated proteins were eluted by adding LSB followed by boiling for 5 min. The eluted
proteins were run on an SDS-PAGE and stained with CBB.
The TRAL bands were excised from the gel. After destaining with 40% ethanol/10% acetic acid,
the proteins were reduced with 20 mM dithiothreitol (Sigma-Aldrich, St. Louis, MO) for 1 hr at 56˚C
and then alkylated with 60 mM iodoacetamide (Sigma-Aldrich, St. Louis, MO) for 1 hr at 25˚C in the
dark. Proteins then were digested with 12.5 ng/mL modified trypsin (Promega, Madison, WI) in 50 mL
of 100 mM ammonium bicarbonate, pH8.9 at 25oC overnight. Peptides were extracted by incubating
the gel pieces with 50% acetonitrile/5% formic acid then 100 mM ammonium bicarbonate, repeated
twice followed by incubating the gel pieces with 100% acetonitrile then 100 mM ammonium bicar-
bonate, repeated twice. Each fraction was collected, combined, and reduced to near dryness in a
vacuum centrifuge. Peptides were desalted using C18 SpinTips (Protea, Morgantown, WV) then
lyophilized and stored at  80˚C.
Peptide labeling with TMT 6plex (Thermo Fisher Scientific, Waltham, MA) was performed per
manufacturer’s instructions. Samples were dissolved in 70 mL ethanol and 30 mL of 500 mM triethy-
lammonium bicarbonate, pH8.5, and the TMT reagent was dissolved in 30 mL of anhydrous acetoni-
trile. The solution containing peptides and TMT reagent was vortexed and incubated at room
temperature for 1 hr. Samples labeled with the six different isotopic TMT reagents were combined
and concentrated to completion in a vacuum centrifuge.
Phosphorylated peptides were enriched as described in (Ficarro et al., 2009). In brief, nickel was
removed from the Ni-NTA Agarose (Qiagen, Valencia, CA) with 100 mM EDTA. The NTA Agarose
was then incubated with 100 mM FeCl3. The peptides were acidified and incubated with the Fe-NTA
agarose for 1 hr at room temperature. Phosophopeptides were eluted with 250 mM sodium
phosphate.
The peptides were separated by reverse phase HPLC using an EASY- nLC1000 (Thermo Fisher
Scientific, Waltham, MA) over a 75 min gradient before nanoelectrospray using a QExactive mass
spectrometer (Thermo Fisher Scientific, Waltham, MA). The mass spectrometer was operated in a
data-dependent mode. The parameters for the full scan MS were: resolution of 70,000 across 350–
2000 m/z, AGC 3e6, and maximum IT 50 ms. The full MS scan was followed by MS/MS for the top
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10 precursor ions in each cycle with a NCE of 32 and dynamic exclusion of 30 s. Raw mass spectral
data files (.raw) were searched using Proteome Discoverer (Thermo Fisher Scientific, Waltham, MA)
and Mascot version 2.4.1 (Matrix Science, Boston, MA). Mascot search parameters were: 10 ppm
mass tolerance for precursor ions; 10 mmu for fragment ion mass tolerance; two missed cleavages
of trypsin; fixed modification were carbamidomethylation of cysteine and TMT 6plex modification of
lysines and peptide N-termini; variable modifications were oxidized methionine, serine phosphoryla-
tion, threonine phosphorylation, and tyrosine phosphorylation. Only peptides with a Mascot score
greater than or equal to 25 and an isolation interference less than or equal to 30 were included in
the quantitative data analysis. TMT quantification was obtained using Proteome Discoverer and iso-
topically corrected per manufacturer’s instructions, and the values were normalized to the median of
the non-phosphopeptides for each channel. Phosphopeptides were manually validated using CAMV
(Curran et al., 2013).
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